Article
Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
BMC research notes - 1 Apr 2016
Papasavva Thessalia, Martin Pete, Legler Tobias J, Liasides Marios, Anastasiou George, Christofides Agathoklis, Christodoulou Tasos, Demetriou Sotos, Kerimis Prokopis, Kontos Charis, Leontiades George, Papapetrou Demetris, Patroclos Telis, Phylaktou Marios, Zottis Nikos, Karitzie Eleni, Pavlou Eleni, Kountouris Petros, Veldhuisen Barbera, van der Schoot Ellen, Kleanthous Marina
Abstract excerpt
BACKGROUND: After the discovery that cell-free fetal DNA (cffDNA) is circulating in the maternal plasma of pregnant women, non-invasive prenatal diagnosis for fetal RhD in maternal plasma in RhD negative women at risk for haemolytic disease of the newborn (HDN) was clinically established and used by many laboratories. The objectives of this study are: (a) to assess the feasibility and report our experiences of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
